# Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes

> **NCT00063583** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sharma, Kumar, M.D.** · enrollment: 77 (actual)

## Conditions studied

- Diabetes Mellitus
- Diabetic Nephropathy

## Interventions

- **DRUG:** Pirfenidone

## Key facts

- **NCT ID:** NCT00063583
- **Lead sponsor:** Sharma, Kumar, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-11
- **Final completion:** 2009-03
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2009-11-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00063583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00063583, "Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00063583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*